Corcept Therapeutics | CORT - Ativos

Preço das Ações
46.06
Mudança Diária
0.98 2.17%
Mensal
13.81%
Anual
-35.77%
Q2 Previsão
45.07




Ativos Alterar Data
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
ANI Pharmaceuticals USD 1.44B 32.22M 2025-12
Ardelyx USD 501.6M 15.43M 2025-12
Assertio Holdings USD 319.77M 46M 2025-09
Aurora Cannabis CAD 775.29M 18.43M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Canopy Growth CAD 1.11B 36.35M 2025-12
Corcept Therapeutics USD 836.65M 13.04M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
J&J USD 200.89B 1.68B 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Lexicon Pharmaceuticals USD 184.99M 20.94M 2025-12
Merck USD 129.55B 12.02B 2025-09
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Novartis USD 110.95B 3.66B 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.26B 32.66M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12